Biotech

Bamlanivimab, Benzinga, Biotech, Coronavirus, COVID-19, General, Health Care, LLY, News, REGN, the National Institute of Allergy and Infectious Diseases, US5324571083, US75886F1075

NIAID Study Finds Eli Lilly’s Antibody Drug Unhelpful For Hospitalized COVID-19 Patients

Eli Lilly and Company (NYSE: LLY) said Monday that a trial of its antibody treatment for use in hospitalized COVID-19 patients has come to an end as the treatment is unlikely to help such patients. 
read more

ABBV, ABMD, AEMD, AGEN, ALIM, ALKS, ALXN, AMGN, APLT, AXGN, AXGT, AZN, BAX, BEAT, Benzinga, BIIB, BIO, Biotech, BNTX, BPMC, BSX, CCCC, CDNA, CERS, CNCE, CNST, DVAX, DXCM, Earnings, EVLO, EXAS, fda, GILD, GMED, IART, IBB, IE00B56GVS15, ILMN, IMNM, INSM, IPOs, jazz, KALA, LGND, LH, LMAT, LUNG, MASI, MEDP, MMSI, MRK, MRNA, NEO, News, NTUS, NUVA, NVCR, OMCL, ONCR, OPK, PCRX, PEN, Penny Stocks, PFE, PLX, PPD, Previews, PTCT, QDEL, RARE, RMD, RTRX, SYNH, TARO, Top stories, Trading Ideas, US0036541003, US00808Y1091, US00847G7051, US0153511094, US0162591038, US0311621009, US0463531089, US0718131099, US0905722072, US09062X1037, US1011371077, US14159L1035, US1570851014, US2521311074, US2681581029, US30063P1057, US3755581036, US4523271090, US4576693075, US4579852082, US4642875565, US4721471070, US50540R4092, US5255582018, US53220K5048, US56804Q1022, US5747951003, US58933Y1055, US5898891040, US6707041058, US68213N1090, US68375N1037, US6951271005, US7170811035, US74365A1016, US74838J1016, US7611521078, US91307C1027, US9216591084, US92532F1003, UTHR, VKTX, VNDA, VRTX, XTNT, ZSAN

The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs

Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and the impasse on fiscal stimulus.
read more

Analyst Color, Analyst Ratings, Benzinga, Biotech, Coronavirus, COVID-19, General, GILD, Health Care, Raymond James, Reiteration, remdesivir, Steven Seedhouse, US3755581036, Veklury

Gilead Analyst: FDA’s Remdesivir Label A Best Case Scenario For Biopharma

Gilead Sciences, Inc. (NASDAQ: GILD) is the first company to receive full FDA approval for a COVID-19 treatment.

Latest Ratings for GILD
DateFirmActionFromTo Sep 2020RBC CapitalMaintainsOutperform Sep 2020RBC CapitalMaintainsOutperform Sep 2020Ma…

abc, Benzinga, Biotech, CAH, Drug Enforcement Agency, General, Government, Health Care, JNJ, Legal, MCK, News, opioid crisis, Pharmaceuticals, U.S. Department of Justice, US03073E1055, US14149Y1082, US4781601046, US58155Q1031, US9311421039, WMT

Walmart Preemptively Sues US Government To Avoid Penalties Related To Opioid Crisis: WSJ

Walmart Inc (NYSE: WMT) has taken preemptive legal action against the federal government to avoid a civil lawsuit against the company related to the operation of its 5,000 in-store pharmacies, the Wall Street Journal read more

ADCT, AERI, ALEC, ALNY, ARTL, ATHA, ATXI, AZYO, Benzinga, BIO, Biotech, BXRX, CDAK, DBVT, DGX, Earnings, EW, fda, FMTX, Fold, GMAB, Guidance, HSDT, IBB, ICPT, IMMU, INSM, JNJ, KALV, LXRX, News, NK, NURO, NVIV, NVRO, Offerings, omer, ONCT, Penny Stocks, PSTV, RHHBY, RMTI, RPRX, TARS, US02043Q1076, US03152W1099, US0905722072, US28176E1082, US4529071080, US4576693075, US4642875565, US4781601046, US5288721047, US6412552035, US6821431029, US74834L1008, US7711951043, US7743741024, US9553061055, WST

The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat

Here’s a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 21)
read more

1 2 3 30